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Abstract
While much of the genetic variation in RNA viruses arises because of the error-prone nature of their RNA-dependent RNA
polymerases, much larger changes may occur as a result of recombination. An extreme example of genetic change is found
in defective interfering (DI) viral particles, where large sections of the genome of a parental virus have been deleted and the
residual sub-genome fragment is replicated by complementation by co-infecting functional viruses. While most reports of
DI particles have referred to studies in vitro, there is some evidence for the presence of DI particles in chronic viral infections
in vivo. In this study, short fragments of dengue virus (DENV) RNA containing only key regulatory elements at the 39 and 59
ends of the genome were recovered from the sera of patients infected with any of the four DENV serotypes. Identical RNA
fragments were detected in the supernatant from cultures of Aedes mosquito cells that were infected by the addition of sera
from dengue patients, suggesting that the sub-genomic RNA might be transmitted between human and mosquito hosts in
defective interfering (DI) viral particles. In vitro transcribed sub-genomic RNA corresponding to that detected in vivo could
be packaged in virus like particles in the presence of wild type virus and transmitted for at least three passages in cell
culture. DENV preparations enriched for these putative DI particles reduced the yield of wild type dengue virus following co-
infections of C6–36 cells. This is the first report of DI particles in an acute arboviral infection in nature. The internal genomic
deletions described here are the most extensive defects observed in DENV and may be part of a much broader disease
attenuating process that is mediated by defective viruses.
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Introduction
Inhibition of viral replication by what would become known as
defective interfering (DI) particles was first described more than 60
years ago with influenza virus [1]. These non-infectious viral
particles [2] were believed, at the time, to have lost an entire RNA
genome segment [3], requiring complementation by a non-
defective homologous virus for reproduction. DI particles, which
now have been observed in a wide variety of viral populations,
arise as a sub-population during infection by wild type virus and
are defined by the following criteria [4]. A DI particle must (1)
contain normal parental viral protein; (2) contain part of the
parental viral genome; (3) require a parental helper virus to
reproduce; and (4) interfere specifically with the intracellular
replication of the parental virus. Populations of viruses containing
‘‘incomplete’’ virions have been found to be less virulent for
experimental animals than the population from which they were
derived [5].
DI particles have been observed most commonly in vitro during
serial passages of viruses at high multiplicities of infection, and
often have been invoked to explain the conversion of acute in vitro
infections to persistent ones [6–11]. A role for DI particles in
maintaining persistent infections in vivo also has been proposed e.g.
measles virus and sub-acute sclerosing panencephalitis [12] and
chronic hepatitis C infections [13,14]. Whether DI particles are
present in acute viral infections that do not lead to chronic
infections in their natural hosts and the role of DI particles in acute
infections are less well documented [15].
Dengue viruses (DENV) are arboviruses in the family Flaviviridae
and are important human pathogens responsible for disease states
described formerly as dengue fever, dengue haemorrhagic fever
and dengue shock syndrome [16]. DENV are transmitted to
humans by Aedes mosquitoes, principally by Aedes aegypti. The four
closely related DENV serotypes are antigenically distinct and often
co-circulate in tropical regions where this disease is endemic. The
nucleotide sequences of the single-stranded positive-sense RNA
genomes of DENV are very diverse, and most viral genomes
recovered from either of the natural hosts contain defects (e.g.
intra-genic stop codons, nucleotide insertions or deletions) that
would render them non-infectious [17,18]. Some of these defects
appear to be maintained during natural cycles of transmission,
presumably due to complementation by fully functional genomes
[18]. We have suggested that these defective genomes impose a
fitness burden on the DENV populations in which they are found
that may result in attenuation of disease severity, allowing greater
mobility of infected human hosts and therefore greater dissemi-
nation of virus [18,19].
In this study, we used a modified 39 RACE protocol to
determine whether sub-populations of DENV in patients con-
tained genomes with large internal deletions similar to those found
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in DI particles in other viral populations [20,21] and whether
viruses with these defective genomes could replicate in the
presence of fully functional DENV.
Results
DENV genomes containing large internal deletions were
detected in sera from dengue patients and in the
corresponding isolates
RNA extracted from sera from dengue patients and from the
corresponding DENV isolates were subjected to modified 39
RACE using oligonucleotide primers corresponding to the 39 and
59 ends of the DENV genome. PCR extension times of 2 minutes
yielded cDNA fragments of approximately 1 kb or less (Figure 1A).
PCR extension times of 6 minutes did not produce larger cDNA
fragments. While cDNAs derived from sera and from their
corresponding isolates usually were of the same size, the number of
bands and their apparent molecular weights appeared to be
characteristic of the DENV serotype. RNA recovered from sera
from 4/8 DENV 1, 2/2 of DENV 2, 2/3 of DENV 3 and 9/9
DENV 4 patients gave rise to low molecular weight bands of
cDNA similar to those shown in Figure 1A (Table S 1).
Low molecular weight cDNA fragments corresponding to those
in Figure 1A were cloned and sequenced. With the exception of
the 550 bp product generated from DENV 3 (discussed below),
cDNA bands from all four DENV serotypes corresponded to
DENV genomes with large internal deletions. The sequences
corresponded to those of the 59 UTR (including the 59 upstream
AUG region [UAR]), the motif downstream of the AUG region
(DAR), some intervening sequence and the 39 end of the 39 UTR
including the 39 conserved sequence (CS) and the 39 UAR
(Table 1). The interface between the 59 and 39 elements included a
variable-length ‘‘overlap’’ sequence found in the 59 and 39 regions
of genomes of the corresponding serotypes (Table 1). The
predicted secondary structure of the 290 nt sub-genomic DENV
2 RNA with all the elements referred to above is shown in
Figure 1B. The AUG codon at the 59 end of the open reading
frame is underlined. The predicted secondary structures of all sub-
genomic RNA in Table 1 resembled that in Figure 1 B, varying
only in the predicted structure of the RNA between the 59 and 39
CS (data not shown).
No non-DENV sequences were detected in these short
fragments of RNA, and there were no nucleotide insertions,
repeats or other aberrations. We were unable to recover sufficient
of the 1100 bp cDNA generated from the serum of a DENV 4
patient (Figure 1 A) to be able to clone and sequence it. The
550 bp fragment derived from the serum of a patient with a
DENV 3 infection and the corresponding isolate corresponded to
the 59 region of the DENV 3 genome attached to a 39 primer used
for PCR.
To determine whether all of these small cDNA fragments could
have been artefacts generated from full length DENV genomes
during RT-PCR, genome length DENV 2 RNA was transcribed
from an infectious clone (pWSK601) and a ten thousand-fold
range of dilutions of the RNA were utilised as templates in
39RACE. No small cDNA fragments were generated when using
primers corresponding to the 39 and 59 ends of DENV genome
(P1), or with primers corresponding to 59 end of DENV genome
and complimentary to the nucleotide sequence of the adapter used
for 39 RACE (P3) (Figure 2 A). Thus, the primers that gave rise to
small cDNA fragments when using RNA from the sera of dengue
patients and from the corresponding isolates (Figure 1 A) failed to
produce small cDNA fragments from in vitro transcribed full length
DENV genomic RNA. In the positive control experiments,
products of the predicted size were produced when using primers
corresponding to an intragenic region of DENV 2 NS5 (P4) or one
of the NS5 primers and a primer complimentary to the adaptor
used for 39 RACE (P2).
As an additional control for ‘‘self priming’’ during PCR [22],
DENV2 isolate 62663 first was treated with 10 mg/ml of RNAse A
for 10 min at 37uC to eliminate any unpackaged RNA or other
RNA contaminant. This treatment was sufficient to destroy at least
50 ng sub-genomic RNA (data not shown). The RT step of the
subsequent 39 RACE was performed with or without a primer. No
product was generated using any combination of primers in PCR
if the RT reaction was performed without a primer (Figure 2 B). In
contrast, two bands of cDNA, the same size as those generated
previously from DENV 2 63662 (Figure 1 A), were observed when
a primer complimentary to the 39adaptor was employed in the RT
reaction.
Detection of sub-genomic RNA in northern blots
C6-36 cells were infected with DENV 2 isolate (61452) which,
in addition to a full length genome, contained 290 nt sub-genomic
RNA that could be detected by RT PCR (Table S1). Total RNA
from infected cells and RNA from virions in the culture
Figure 1. cDNA generated by 39 RACE using primers corre-
sponding to the 39 and 59 ends of the DENV genome.
(A) Employing RNA extracted from sera [S] from dengue patients or
from the corresponding isolates [I] (B) Predicted secondary structure of
the 290 nt sub-genomic DENV 2 RNA showing elements referred to in
the text. The AUG codon at the 59 end of the open reading frame is
underlined.
doi:10.1371/journal.pone.0019447.g001
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supernatant were extracted 5 and 8 days post-infection. Northern
blot analyses were performed using DIG-labelled negative-sense
RNA probes corresponding to the DENV2 591-206 nt (59-probe)
or the 3910526-10723 nt (39-probe). Genomic length DENV 2
RNA transcribed from infectious clone pWSK601and a 290 nt
sub-genomic fragment of DENV 2 RNA transcribed from a
plasmid containing the corresponding cDNA (Table 1) were
recognised by both the 59 and 39 probe (Figure S1). Neither probe
recognised RNA from uninfected cells. While it was possible to
detect sub-genomic (,290 bp) DENV RNA in infected cells and
in supernatant from the infected cultures, the 39 probe hybridised
only weakly with genome length RNA from supernatant, perhaps
reflecting the limited sensitivity of the assay (approximately 10 pg
RNA),
Negative strand sub-genomic RNA in DENV-infected cells
A strand-specific RT-PCR was employed to detect negative
strand sub-genomic RNA in putative double strand replicative
intermediates in DENV 2 (61452) infected C6-36 cells. The assay
allowed approximately 1,000,10,000 fold discrimination be-
tween positive and negative strand RNA using template
concentrations between 0.001 and 1 pg of DENV 2 sub-genomic
positive and negative strand RNA (Table 2). Negative strand
RNA corresponding to the 290 nt fragment was detected in cells
2, 5 and 8 days post-infection as was corresponding positive
strand RNA. The differences between copy numbers for negative
and positive strand RNA were too small (see discriminatory
values above) for the values for negative strand RNA to have
been an artefact.
DENV particles containing sub-genomic RNA could be
generated from WT DENV-2 in vitro
To determine if DENV particles containing sub-genomic
RNA could be generated in vitro from a virus stock that
contained only full length genomes, C6/36 mosquito cells were
transfected with RNA that had been transcribed from a DENV-
2 infectious clone (pWSK601). This culture was maintained by
replacing the culture medium and assaying for sub-genomic
DENV RNA every seven days. Sub-genomic DENV RNA was
not detected in the supernatant from these cultures until 28 days
post-infection (Figure 3 A). To simulate successive infection
cycles, culture supernatant recovered 7 days after transfection of
the C6/36 cells was passaged at intervals of 7 days in C6/36
mosquito cells, HuH7 human liver cells or in alternating
passages of C6/36 and HuH7 cells. While sub-genomic DENV
RNA was not detected in the culture supernatant until after four
passages (28 days) in C6/36 mosquito cells (Figure 3 B), it could
be detected after only one passage (7 days) in HuH7 human cells
(Figures 3 C and D). The three small cDNAs derived by 39
RACE with RNA from the supernatants of these cultures (288,
362, 391 bp) were cloned and sequenced. They corresponded to
the 59 and 39 ends of the genome of the DENV 2 infectious
clone and differed only at the point at which these elements had
combined (Table 1, DENV 2 derived from infectious clone).
Table 1. Nucleotide sequences at the putative junction between 59 and 39 regions of DENV genomes in sub-genomic RNA.
Source of RNA
size of
cDNA(bp) 59 sequence{ 39 sequence{ Nucleotide sequence at overlap region {
D1-67380 serum 370 nt 1-257 nt 10620-10735 59 ATAGCATTCCTAAGATTTCTAGC267 10610ACCCCCGGCATAACAATAAACAG 39
D1-67380 isolate 370 nt 1-257 nt 10620-10735 59 ATAGCATTCCTAAGATTTCTAGC267 10610ACCCCCGGCATAACAATAAACAG 39
D2-63662 serum 290 nt 1-179 nt 10607-10723 59GTCGACTGTG-AACAGGCCCTGG187 10595 AGACCCCCCCGAAACAAAAACAGCAT39
400 nt 1-213 nt 10526-10723 59 CTCACTTGGAAT-GCTGCAAGGGAC218 10512CTCCCTTACAAATCGCAGCAACAATG39
D2-63662 isolate 290 nt 1-179 nt 10607-10723 59GTCGACTGTG-AACAGGCCCTGG187 10595 AGACCCCCCCGAAACAAAAACAGCAT39
400 nt 1-213 nt 10526-10723 59 CTCACTTGGAAT-GCTGCAAGGGAC218 10512CTCCCTTACAAATCGCAGCAACAATG39
D3-66178 serum 400 nt 1-189 nt 10489-10684 59GTTGGCGAAGAGATTCTCAAAAA199 10480CAGACTAGCGGTTAGAGGAGAC39
D3-66178 isolate 400 nt 1-189 nt 10489-10707 59GTTGGCGAAGAGATTCTCAAAAA199 10480CAGACTAGCGGTTAGAGGAGAC39
D4-61673 serum 510 nt 1-404 nt 10534-10650 59GGAAAAGGTCAACATAACATTGCT414 10524GAGACCCCCCCAACACAAAAACAG 39
690 nt 1-336 nt 10284-10650 59 ACAAGGCCATAAAGATACTAACTGG336 10274 AAAAAACACCAAAGAGGCTATTGAA 39
830 nt 1-293 nt 10094-10650 59ACCAACAGCAGGGATTCTGAAAAGAT301 9995 GGAAAAGAGAGGATTTGTGGTGTGG 39
D4-61673 isolate 510 nt 1-404 nt 10534-10650 59GGAAAAGGTCAACATAACATTGCT414 10524GAGACCCCCCCAACACAAAAACAG 39
690 nt 1-336 nt 10284-10650 59 ACAAGGCCATAAAGATACTAACTGG336 10274 AAAAAACACCAAAGAGGCTATTGAA 39
1030 nt 1-335 nt 9620-9712
nt 10037-10650
59ACAAGGCCATAAAGTACTAACTGG344 9610ACGACATGGGAAAGGTGAGGAAAG 39
59ACTTCCACAAGATCTTTATGAAG9723 10027ACCCTAATATGATTGACAAAACTC 39
DENV2 derived
from infectious
clone
391 nt1-190 10523-10724 59 GCTGACAAAGAGATTCTCACT200 10513CCCCTCCCTTACAAATCGCAGCAA 39
DENV2 derived
from infectious
clone
362 nt1-177 10536-10724 59 TGTCGACTGTACAACAGCTGAC177 10528TCGCAGCAACAATGGGGGCCCAA 39
DENV2 derived
from infectious
clone
288 nt1-173 10609-10724 59GTCGACTGTACAACAGCTGGACA187 10599GACCCCCCCAAAACAAAAAACAGC39
The reference sequences for DENV-1, 2, 3 and 4 are AY726554.1, AF169688.1, FN429913.1 and AY618990.1 respectively. The accession number of the sequence of the
DENV 2 infectious clone is AF038403.1.
{Sequence of the cDNA derived from subgenomic RNA is shown in bold. The sequence in plain text is from the corresponding reference sequence, and the underlined
sequence is the overlap.
doi:10.1371/journal.pone.0019447.t001
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The overlap between the 39 and 59 ends of the 288 nt sub-
genomic RNA generated in vitro from genome length RNA
derived from the infectious clone occurred in the same region as
the overlap between the 39 and 59 ends of the 290 nt sub-
genomic RNA from the serum of a dengue patient. The nt
sequence (ACA) at the junction of the 288/290 sub-genomic
RNAs was the same as that at the junction of the 39 and 59 ends
of the 362 nt sub-genomic RNA generated during passage of the
infectious clone-derived DENV 2 (Table 1).
WT DENV complemented defective DENV RNA in cell
culture
To determine if wild type DENV could complement sub-
genomic DENV RNA in trans to yield particles containing sub-
Figure 2. Effect of the concentration of DENV 2 RNA template and of the primers used for reverse transcription in 39RACE on the
generation of cDNA. (A) Analysis of cDNA produced following 39 RACE employing ten-fold dilutions of RNA transcribed from a DENV 2 infectious
clone as template and a variety of primer combinations [P1, D2-59UTR-F and D2-39UTR; P2, D2-9678-F and adaptor 2; P3, D2-59UTR-F and adaptor 2;
P4, D2-8375-F and D2-8885-R]. (B) cDNA generated following 39 RACE RT-PCR with RNA from a DENV 2 isolate as template and the RT step performed
with or without an oligonucleotide primer and a variety of primer combinations in PCR. [P1, D2-59UTR-F and adaptor 2; P2, D2-9678-F and adaptor 2;
P3, D2-59UTR-F and D2-39UTR-R; P4, D2-8375-F and D2-8885-R].
doi:10.1371/journal.pone.0019447.g002
Table 2. Number of copies of negative and positive strand sub-genomic RNA (log10) in DENV 2 (61452) infected C6-36 cells.
Sense primer in RT Anti-sense primer in RT
Control RNA Neg. strand RNA Pos. Strand RNA Neg. strand RNA Pos. Strand RNA
1 pg RNA 6.7 2.9 3.0 6.8
0.1 pg RNA 5.7 2.0 2.3 5.7
0.01 pg RNA 4.7 1.4 1.9 4.7
0.001 pg RNA 3.7 0.8 1.0 3.8
Cellular RNA
Day 2 post infection 4.5 5.2
Day 5 post infection 4.3 5.0
Day 8 post infection 4.1 5.9
doi:10.1371/journal.pone.0019447.t002
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genomic RNA, C6/36 cells were infected with DENV 2 derived
from infectious clone cDNA (pWSK601, no detectable defective
RNA) and then transfected 24 h later with a 290 nt RNA that
was transcribed in vitro from cloned cDNA (pUC-D2-DI)
corresponding to the 290 nt sub-genomic DENV 2 RNA
(Table 1). DENV 2 infected C6/36 cells also were mock
transfected or transfected with RNA corresponding to the 59-
terminal 370 nt of the DENV 2 genome. Uninfected C6/36
cells were transfected with the 290 nt DENV RNA as an
additional control. At each passage, culture supernatant was
treated with mixture of RNase A and RNase T1, to digest any
unprotected RNA contaminant, prior to RNA extraction.
DENV 2 290 nt sub-genomic RNA was detected in the culture
supernatant from DENV 2 infected C6/36 cells 5 days after
transfection with DENV 2 290 nt RNA but not in culture
supernatant from un-infected cells (not shown), or from DENV 2
infected C6-36 cells that had been mock transfected or
transfected with the RNA corresponding to the 59 370 nt of
the DENV 2 genome (Figure 4 A). Supernatant from these
cultures were passaged a further two times in C6/36 cells at
intervals of 7 days. Decreasing numbers of copies of DENV 2
290 nt sub-genomic RNA were detected with each passage
(Figure 4 A). While there were no differences between the titres
of DENV in the supernatant of cultures infected with DENV 2
and mock transfected or infected with DENV 2 and transfected
with 59 DENV RNA (Figure 4 B), the titres of DENV 2 in
supernatant from cell cultures infected with DENV2 and
transfected with the 290 nt RNA were significantly lower
(p#0.05, student t-test) than the titres of DENV2 in cultures
of C6-36 cells infected with DENV 2 and mock transfected or
transfected with 59 DENV RNA. No infectious DENV was
detected in the supernatant from cultures of uninfected C6-36
cells transfected with sub-genomic RNA.
There was a significant excess of sub-genomic DENV RNA
over full length DENV RNA in the cells infected with DENV 2
and transfected with sub-genomic RNA (p#0.01, student t-test)
(Figure 5). However, in the accompanying culture supernatant, the
ratio of full-length to sub-genomic RNA was almost 1:1. By
passage 3, the ratios of full-length to sub-genomic DENV RNA in
cells and in the corresponding culture supernatant were almost the
same and there was a significant excess of full length over sub-
genomic RNA (p#0.01, student t-test).
Figure 3. Generation of sub-genomic DENV 2 RNA during passage of wild type virus. DENV 2 derived from an infectious clone was
passaged in C6-36 cells, in HuH7 cells or alternatively in both cell types. (A) C6-36 cells infected with infectious clone-derived virus and culture
supernatant sampled at the times shown. (B) Virus passaged to uninfected cultures of C6-36 cells every 7 days. (C) Virus recovered from cultures of
C6-36 cells after 7 days and thereafter passaged to uninfected cultures of HuH7 cells every 7 days. (D) Virus recovered from cultures of C6-36 cells
after 7 days and thereafter passaged, alternately, into uninfected cultures of HuH7 cells or C6-36 cells every 7 days. (P2, passage 2; P3 passage 3 etc).
doi:10.1371/journal.pone.0019447.g003
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Figure 4. Replication of sub-genomic RNA in the presence of wild type virus. (A) Yield of sub-genomic (SG) DENV 2 RNA in cultures infected
with infectious clone-derived DENV 2 and mock transfected (no RNA) or transfected with sub-genomic DENV 2 RNA corresponding to that detected
in serum from dengue patients or with a control RNA preparation (D2-59RNA, RNA corresponding to the 59 370 nt of the DENV 1 genome). (B) Yield of
infectious virus from the cultures in (A). An asterix indicates the titres were significantly different (p,0.05, student t-test).
doi:10.1371/journal.pone.0019447.g004
Figure 5. Comparison of the ratios of sub-genomic to genome length DENV RNA in C6-36 cells infected with infectious clone-
derived DENV 2 and transfected with sub-genomic DENV 2 RNA and in the accompanying culture supernate (from Figure 4). One
hundred ng of RNA from infected cells and RNA from the equivalent of 1 ul of culture supernate were used in the quantitative RT PCR reactions.
doi:10.1371/journal.pone.0019447.g005
Dengue Virus DI Particles
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Populations of DENV enriched for particles containing
sub-genomic RNA inhibited replication of WT DENV in
vitro
In an attempt to separate DENV 2 virions with full length
genomes from particles containing sub-genomic RNA, a DENV 2
virus stock (isolate 61452) that contained sub-genomic DENV
RNA was centrifuged on 5–50% w/v sucrose/PBS gradients. Ten
fractions were collected (fraction 1, at the bottom of the gradient,
was the most dense) and assayed for infectivity by plaque assay
(Figure 6 A) and for DENV E protein by dot blotting (Figure 6B).
Quantitative RT-PCR was used to quantify the 290 nt sub-
genomic RNA and a region of the NS5 gene which served as a
surrogate for full length DENV genomes (Figure 6 C). The highest
titres of infectious virus were detected in fractions 4, 5 and 6
(Figure 6A). Although the DENV envelope (E) protein was
detected in all gradient fractions, its concentration in each fraction
mirrored the titres of infectious virus. Putative full length DENV 2
genomes also were most abundant in those fractions that
contained most infectious virus (Figure 6 C). Most 290 nt sub-
genomic RNA was detected in fractions 1, 2, 3, 8, 9 and 10, where
infectious virus was less abundant. The elevated levels of sub-
genomic RNA in denser fractions (1, 2 and 3 at the bottom of the
gradient) which were accompanied by reduced virus titres, may
reflect aggregates of viral particles containing the 290 nt sub-
genomic RNA.
To determine if the gradient fractions containing the sub-
genomic DENV 2 RNA interfered with the replication of
homologous, infectious virus, aliquots from gradient fraction 5,
which contained most infectious virus, were mixed with an equal
volume of each gradient fraction and used to infect C6/36 cells.
The titre of infectious virus in the supernatant from these cultures
was determined 7 days post -infection using an infectious focus
assay on BHK – 21 clone 15 cells. Addition of aliquots from
fractions 3, 8, 9 and 10 caused a significant reduction (p,0.05;
student t-test) in the yield of virus from C6-36 cells infected with
DENV from gradient fraction 5 (Figure 6 D).
Discussion
Sub-genomic DENV RNAs, representing each of the four
DENV serotypes, were detected in sera from most dengue patients
and from the corresponding isolates by 39 RACE. Subsequent
investigations, focussing on DENV 2, provided evidence of DEN
virus-like particles that satisfy the criteria for DI particles [4].
While there is an extensive literature describing DI particles
produced in vitro or in other experimental systems [9], this is the
first report, to our knowledge, of DI particles in an acute viral
infection in humans. Others have identified large deletions in the
genomes of viruses like Hepatitis A, which also cause acute
infections [15], but they have not satisfied the remaining criteria
for DI particles. While there is an extensive literature elaborating
the RNA elements required to generate negative and positive
strands of flavivirus RNA and for packaging of the RNA in vitro or
in experimental systems [23–28], this study points to the minimum
elements required for these activities during natural cycles of
transmission.
For the following reasons, we do not believe the short pieces of
cDNA, which corresponded to DENV RNA with all the key
elements required for its replication [23,24] were in vitro artefacts.
No cDNA was detected following PCR if the primer was omitted
from the RT step (Figure 2 B) i.e. the cDNA fragments were not
artefacts resulting from ‘‘self-priming’’ in PCR reactions [22]. The
RT PCR reactions which generated the short cDNA fragments
from RNA from sera from some dengue patients failed to generate
short fragments of cDNA when a wide range of concentrations of
RNA transcribed from a DENV 2 infectious clone was employed
(Figure 2 A) or when RNA was recovered from infectious DENV 2
derived from C6-36 cells transfected with this RNA (Figure 3 B,
passages 2 and 3). However, RT PCR employing RNA recovered
after prolonged culture or repeated passage (Figure 3 A and B) of
the same DENV 2 derived from this infectious clone gave rise to
short pieces of cDNA almost identical to those detected when
using sera from patients infected with DENV 2 (Table 1).
While it was possible to detect 290 nt sub-genomic DENV RNA
in infected cells using probes corresponding to 59 and 39 regions of
the DENV 2 genome (Figure S1), the equivocal results obtained
when attempting to detect these short pieces of RNA in culture
supernatant from DENV 2 infected cells using northern blots, may
have been due to the limited sensitivity of our assay. Detection of
negative strand RNA corresponding to this sub-genomic 290 nt
RNA (Table 2) in C6-36 cells infected with a DENV 2 population
which contained the corresponding piece of positive sense sub-
genomic RNA, suggested that the 290 nt positive strand of RNA
was being replicated or that new sub-genomic negative strand
RNA was being produced or that both processes were occurring in
the infected cells (see below). The ratio of positive to negative
strand sub-genomic RNA was similar to that described previously
for full length DENV genomes [29].
The nucleotide sequences of the DENV DI RNA usually
contained a variable-length, A-rich, sequence at the crossover site
that was shared by both the 59 and 39 elements in the full length
DENV genome (Table 1). This is a hallmark of imprecise
recombination by the copy-choice mechanism during RNA
replication [30], in which the replication complex ‘‘jumps’’ from
a recombination hotspot on one RNA strand to an homologous
sequence on a second similar or identical RNA strand. The CS
and UAR sequences of the DENV genome are believed to bring
the 39 and 59 ends of the genome together such that it forms a
‘‘panhandle’’ structure [23–28]. The RdRP then binds to the 59
end of the genome in order to initiate negative strand RNA
synthesis at the adjacent 39 end of the genome. Intriguingly, these
features also might facilitate a novel intra-strand recombination
mechanism to produce DENV DI RNA de novo. As circularisation
of the DENV RNA genome brings the 59 and 39 ends into close
proximity, recombination could occur in cis between two adjacent
homologous sequences near the 59 and 39 ends of the genome
(Table 1) during negative strand synthesis resulting in the deletion
of the majority of the genome. It has been suggested that
alphavirus DI particle RNA with large internal deletions may arise
by sequential deletion events [31]. However, the failure to detect
any DENV RNAs of between approximately 1 and 6 Kb suggests
that shortening of the DENV genome does not occur in a similar
stepwise manner. From the discussion above, it seems unlikely that
the sub-genomic RNA detected in these DENV infections arose by
a similar mechanism, or plays a similar role, as the 300–500
nucleotide sub-genomic fragments from the 39 region of the
genome of West Nile virus described elsewhere [32].
The observation that a 290 nt strand of positive sense RNA,
corresponding to that detected in infected cells, could be packaged
into particles if fully functional genomes were present (Figure 4) is
in agreement with the previous observation that Yellow Fever
virus could encapsidate RNA in trans [33] but contrasts with
reports that Kunjin virus appears unable to do so [34,35]. This
may reflect a segregation of encapsidation processes between
encephalitic and haemorrhagic members of the flavivirus genus.
When infected with DI particle-free DENV, the human cell line
(HuH7, liver) produced sub-genomic RNA more rapidly than did
mosquito cells (Figure 3). Alternate passage of extracellular virus in
Dengue Virus DI Particles
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human and mosquito cells did not eliminate particles containing
sub-genomic RNA. However, RNA recovered from culture
supernatants during the first two passages in HuH7 cells and the
first alternating passages in C6-36 and HuH7 cells gave rise to
cDNA of varying sizes (Figure 3 C,D) suggesting that some short
RNAs were being lost and new ones generated until an optimal
form of the short RNA was reached. The 28 days required for DI
particles to appear in mosquito cells is much longer than the life of
Figure 6. Properties of DENV 2 particles separated by centrifugation on a 5–50 per cent continuous sucrose gradient. (A) Titre of virus
in each gradient fraction and in the DENV 2 stock (S) added to the gradient (fraction 1 contains 50% sucrose/PBS and fraction 10, 5% sucrose/PBS).
(B) Titre of envelope protein detected by indirect ELISA on gradient fractions blotted onto nitrocellulose membrane. (C) DENV 2 NS5 and 290 nt DENV
2 RNA quantified by qPCR (D) Titre of DENV 2 in culture supernatant seven days after sucrose gradient fractions were mixed with gradient fraction 5
and used to infect cultures of C6-36 cells.
doi:10.1371/journal.pone.0019447.g006
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most Aedes aegypti mosquitoes in nature (average 8.6 days [36]),
while the 7 days or less required for the appearance of DI particles
in human cells would be sufficient time for them to be generated
and included in a blood meal taken by a mosquito from a human
host [37]. It is not clear why DI particles were not detected in all
patients infected with the same DENV serotype during the same
outbreak (Table S 1). It is possible that the 39 RACE protocol
employed lacked the necessary sensitivity. Alternatively, some host
factors may be in play which rapidly eliminate DI particles or
which restrict their formation e.g. the temperature or duration of
fever might influence the fidelity of the RdRP or the frequency of
recombination, if that is how DENV genomes with large internal
deletions are derived. Nonetheless, these observations raise the
possibility that DENV DI particles are not transmitted efficiently
from host to host and that they usually arise de novo. The biological
significance of our observations may depend on which of these two
processes are in play, although they are not mutually exclusive.
However, the course of an infection in a human infected with a
mixture of wild type and DI DENV may be different to that in
someone who only begins to generate significant numbers of DI
particles 5–7 days after being infected (Figure 4D). Since there
appears to be a correlation between levels of viraemia in dengue
patients and disease severity [37], production of DI particles
which, in turn, reduced viraemia has the potential to attenuate
symptoms. This is unlikely to be an all-or-none phenomenon and
the data in Figures 4 and 5 suggest that there may need to be a
large excess of sub-genomic to genomic DEN RNA for any
significant dampening of a viraemia.
Several replicative steps might be inhibited by DENV DI
particles or their genomes. The first is competition for ribosomes
after release of RNA from infecting virus particles; a second may
be competition with functional genomes for NS5 and associated
replicative complex proteins – the sub-genomic RNA retained all
elements required for its replication. Another is competition with
functional genomes for capsid proteins. The second would have a
direct effect on the number of full-length genomes produced and
it is compatible with the observation that large numbers of sub-
genomic RNAs/DI particles were needed to reduce the output of
functional, infectious virus (Figures 4–6). Models of DENV RNA
replication suggest that up to five nascent strands of positive sense
RNA may be generated from a single Replicative Intermediate
(RI) [38]. However, RIs of the sub-genomic RNAs detected in
this study probably would be too short to accommodate more
than one nascent strand. In these circumstances, DI particles
containing sub-genomic RNA may need to be in significant
excess in order to overcome the replicative advantage of long
genomes able to support simultaneous production of multiple new
genomes.
DENV DI particles may not be a novel aspect of DENV biology
but part of a broad spectrum of defects in the viral genome which
attenuate disease and make these viruses very effective parasites.
Attempts to correlate DENV DI particle numbers in patients with
the severity of symptoms were thwarted, in part, by a lack of
sufficient subjects with severe symptoms. However, since DENV
populations in patients contain large numbers of virions with
defective genomes [17,18,39], it would have been impossible to
distinguish the effects due to DI particles with genomes containing
the large deletions observed in this study from those due to full
length genomes with defects or due to genomes with small
numbers of nucleotide insertions or deletions. We propose that
DENV DI particles and virions with full length, but defective,
genomes which are unable to generate infectious progeny, reduce
the severity of symptoms in humans, enabling those with mild
disease to remain mobile and to disseminate DENV more widely
than can Aedes mosquitoes whose average flight range is
approximately one hundred metres [40,41]. Human mobility has
been shown to be critical to the maintenance of cycles of
transmission of vector-borne viral diseases [19].
Materials and Methods
Ethics statement
This study was approved by the Queensland University of
Technology Research Ethics Unit (Ethics No. 0700000910). As no
patient tissue was employed in this study, the University Ethics
Unit did not require informed patient consent. All patient
identifiers were removed from dengue virus samples before they
were used for research purposes.
Cells and sera
Aedes albopictus mosquito cells (C6/36) were maintained at 30uC,
and human hepatocellular (HuH7) and BHK-21 clone 15 cells
[42] at 37uC in RPMI 1640 (Gibco, USA) supplemented with
5% v/v fetal calf serum (FCS) and 100 U/ml penicillin, 100 mg/ml
streptomycin and 2 mM glutamine (Gibco, USA) (growth medium).
Sera were collected from dengue patients by venepuncture
(Ethics approval QUTHREC0700000910). DENV were recov-
ered from the sera by culturing them with C6/36 cells for 7 days at
30uC. The viruses were serotyped by indirect immunofluorescence
employing serotype specific monoclonal antibodies [43]. Virus
isolates were stored at 280uC until required.
39 rapid amplification of cDNA ends (RACE) for detection
of sub-genomic DENV RNA
RNA was extracted from sera, virus isolates or from sucrose
gradient fractions using QIAamp Viral RNA Mini purification kits
(QIAGEN, Germany), and from DENV infected cells using
NucleoSpin RNAII purification kits (Macherey-Nagel, Germany)
according to the manufacturer’s instructions. The 39RACE
procedure was a modification of an earlier protocol [44]. Briefly,
an oligonucleotide primer (adaptor primer 1, Table S2) was ligated
to the 39 end of RNA extracted from DENV or DENV-infected
cells using RNA ligase (Promega, USA) according to the
manufacturer’s instructions. Reverse transcription was performed
using adaptor primer 2 (Table S2), the sequence of which was
complementary to that of adapter primer 1, and superscript III
reverse transcriptase (Invitrogen, USA) following the product
protocol. In the subsequent PCR reaction, various primer
combinations were used. The principal primer combination was
a pair corresponding to the 59 and 39 ends of the DENV genome.
Since the 59 sequences of DENV 1-3 are conserved, a pair of
primers (D2-59UTR-F and D2-39UTR-R) could be used for the
samples of DENV 1-3. The primers employed for amplification of
DENV-4 cDNA were D4-59UTR-F and D4-39UTR-R (Table S2).
Other primer combinations included D2-59UTR-F and adapter
primer 2, D2-9678-F and adapter 2, and D2-8375-F and D2-
8885-R. Unless indicated otherwise, the PCR reactions were
carried out with one cycle at 94uC for 2 min followed by 40 cycles
of 94uC for 30 sec, 56uC for 30 sec and 72uC for 2 min and
completed with one cycle of 72uC for 10 min.
In order to determine the sequences of the cDNA generated,
the PCR products were cloned and sequenced. An A-tail was
added to both ends of PCR products using Taq polymerase
(Promega, USA) and dATP. The A-tailed product was ligated into
pGEM-T vectors (Promega, USA) according to manufacturer’s
instruction and used to transform E. coli DH5a. Plasmids were
recovered from colonies of bacteria which grew on Luria-Bertani
agar supplemented with 100 mg of amplicillin/ml, 0.5 mM
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isopropyl-b-D-thiogalactopyranoside (IPTG), and 80 mg of bro-
mo-4-chloro-3-indoyl-b-D-galactosidase/ml using QIAprep Mini-
prep kits (Qiagen, Germany).Inserts in the plasmids were
sequenced using M13 primers on an automated sequencer (ABI
Prism, Australian Genome Research Facility).
Predictions of the secondary structures of sub-genomic RNAs
were obtained using software available at http://mfold.rna.albany.
edu/ [45].
Quantitative real-time PCR
RNA was reverse transcribed at 50uC for 1 h using Superscript
III RT (Invitrogen, USA) and random oligonucleotide primers
(Roche, Switzerland). PCR was performed on a Roter-Gene-6000
real-time PCR machine (Corbett, Australia) using Light Cycler
FastStart DNA Master Plus SYBR green I (Roche, Switzerland)
according to the manufacturer’s instructions. Cycling conditions
were 1 cycle of 95uC for 10 min followed by 40 cycles of 95uC for
10 sec, 58uC for 10 sec and 72uC for 30 sec. DENV-2 sub-
genomic RNA was quantified using primers D2-59UTR-F and
D2-39UTR-R (Table S2) and a region of the NS5 gene quantified
using primers D2-8375F and D2-8885R (Table S2), as a surrogate
for a full length genome.
Strand-specific RT-PCR
Positive and negative sense RNA that was used as controls in
the strand-specific RT-PCR was transcribed from pGEM-D2-DI
plasmid (see below) using T7 and sp6 polymerases respectively. In
RT reactions, various amounts of positive and negative strand
RNA was mixed with primer D2-39UTR-R (for positive strand
detection) or with primer D2-59UTR-F (for negative strand
detection) and denatured at 90uC for 3 min, RT reactions were
carried out at 65uC for 1 h in the presence of Thermscript
Reverse Transcriptase (Invitrogen, USA) followed by heating to
85uC for 10 min to inactivate the RT. The RT products then
were treated with 200 U/ml RNase H and 1000 U/ml RNase
T1 for 10 min at 37uC. The qPCR was performed on a Roter-
Gene-6000 real-time PCR machine (Corbett, Australia) using
Light Cycler FastStart DNA Master Plus SYBR green I (Roche,
Switzerland) and primers D2-59UTR-F and D2-39UTR-R (Table
S2). Cycling conditions were 1 cycle of 95uC for 10 min followed
by 35 cycles of 95uC for 10 sec, 58uC for 10 sec and 72uC for
30 sec.
Transcription of RNA from plasmids and transfection of
C6-36 cells
Plasmid pWSK601, coding for the genome of DENV 2 [46],
was a gift from Dr Andrew Davidson, Monash University
Australia. Plasmids pGEM-D2-59-206 and pGEM-D2-39-10526
were constructed by inserting PCR fragments corresponding to
DENV2 nt 1-206 or nt 10526-10723 into a pGEM-T vector.
These fragments were derived from plasmid pSWK601 by PCR
employing primers D2-59UTR-F and D2-206-R (pGEM-D2-59-
206) and primers D2-10526-F and D2-39UTR-R (pGEM-D2-39-
10526). Plasmid pGEM-D2-DI was pGEM-T with a 290 nt
cDNA insert corresponding to the 290 nt DENV 2 sub-genomic
RNA detected in serum from a patient with a DENV 2 infection
i.e. nt 1-190 from the 59 end of the genome linked to nt 10526-
10723 from the 39 end of the genome. pUC-D2-DI was
constructed by inserting a T7 promoter sequence and the 290 nt
DENV 2 sub-genomic ds-cDNA into a pUC18 vetor. A control
plasmid, pUC-DENV-59 contained the T7 promoter sequence,
cDNA corresponding to the 59 373 nucleotides from DENV 1 and
a D2-39XbaI-R primer sequence (Table S2).
Plasmids were linearized by treatment with the corresponding
restriction enzyme followed by column purification (Roche).
Transcription was performed using the MEGAscript transcrip-
tion system (Ambion, USA) according to the manufacturer’s
instruction.
C6/36 cells were transfected by electroporating 107 cells in
0.5 ml PBS with 10 mg of RNA, transcribed from one of the
plasmids above, in a Gene Pulser II (Bio-Rad, USA) at 550 mF and
250 V. After electroporation, the cells were diluted in fresh growth
medium and transferred to a 25 cm2 tissue culture flask at 30uC.
The next day, the growth medium was replaced with fresh
medium and the cells incubated for a further 6 days. Supernatant
from this culture was used to infect a fresh flask of C6/36 cells in
order to prepare working stocks of virus.
Northern Blot
Plasmids pGEM-D2-59-206 and pGEM-D2-39-10526 were
linearized using restriction enzyme Sac II followed by purification
with a PCR purification Kit (Roche, Germany). DIG-labelled
negative strand RNA probes were synthesised from this linearised
DNA using sp6 polymerase from a DIG Northern Starter Kit
(Roche) according to the manufactures instructions. Briefly, RNA
was denatured in loading buffer for 10 min at 65uC and separated
in 1.2% formaldehyde agarose gels followed by capillary transfer
onto positive charged nylon membrane (Roche, Germany) and
UV crosslinking with 250 nm UV light for 2.5 min. The
membrane was prehybridized in hyb granules buffer for 30 min
and then hybridized with probe for 6 h at 68uC. After stringent
washes, the membrane was blocked with block buffer from the kit
followed by incubation with alkaline phosphatase-labelled anti-
DIG antibody for 30 min at RT. The membrane then was washed
twice in wash buffer and incubated in CDP-Star agent at RT for
5 min before being exposed to photographic film (Agfa, Belgium).
Sucrose gradient centrifugation
Two ml of supernatant from cultures of C6/36 cells infected
with DENV-2 (D2Myanmar08.61452), in which a 290 nt sub-
genomic DENV RNA had been identified, was loaded on a 10 ml
5–50% w/v sucrose/PBS (pH 7.4) gradient and centrifuged at
25,000 r.p.m. for 2.5 h at 4uC in an SW40 rotor (Beckman, USA).
Fractions (1 ml) were collected from the gradient by puncturing
the bottom of the centrifuge tube.
Dot blotting
Supernatant from cultures of DENV 2 infected C6-36 cells or
fractions from sucrose gradients were diluted 10-fold in PBS and
100 ml aliquots were added to nitrocellulose membrane (Amer-
sham Biosciences, Sweden). The membrane then was blocked in
4% w/v skim milk (Diploma, New Zealand) and 1% v/v FCS in
PBS at 4uC overnight before being incubated in HRP-labelled
anti-flavivirus antibody (6B6C.1, Panbio, Australia) in blocking
buffer for 1 h at room temperature. After four washes in PBS, the
nitrocellulose was incubated with lumi-light western blotting
substrate (Roche, Germany) for 5 min and then exposed to
photographic film (Agfa, Belgium).
Infectious focus assay
Ten fold dilutions of virus in culture medium supplemented
with 2% v/v FCS were added to monolayers of BHK-21 clone 15
cells in 24 well plates (Thermo Fisher Scientific, Denmark),
incubated at 37uC for 1 h and then overlayed with 1 ml of
1.5% w/v carboxymethylcellulose (BDH, UK) in culture medium
containing 2% v/v FCS. After 4 days at 37uC, the CMC overlay
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was removed and the cells were fixed with 5% v/v formaldehyde/
PBS for 30 min followed by 5 min incubation in 5% v/v Triton-
X-100/PBS. After discarding the Triton-X-100 and washing twice
with PBS, 2% w/v skim milk/PBS was added for 30 min at room
temperature. The blocking buffer then was replaced with HRP-
6B6C.1 antibody diluted in blocking buffer and incubated for 1 h
at room temperature. After 4 washes with PBS, 200 ml of insoluble
tetramethylbenzidine solution (Sigma, USA) was added to the cell
monolayers and incubated at room temperature until well defined
foci were visible.
Supporting Information
Figure S1 Northern blot analysis of RNA from DENV 2
isolate (61452) and from C6-36 cells infected with this
virus. (A) Blots probed with a DIG-labelled probe complemen-
tary to the DENV2 591-206 nt (59-probe). Gen., genome length
RNA transcribed from DENV 2 infectious clone pWSK601; SG,
290 nt sub-genomic DENV 2 RNA transcribed from plasmid
pGEM-D2-DI; UC, cellular RNA from uninfected C6-36 cells;
Cellular RNA, from cultures of C6-36 cells infected with DENV 2
[61452] 5 or 8 days previously; RNA from Supernatant, RNA
recovered from the supernatant of the cultures of C6-36 cells
infected with DENV 2 [61452] 5 or 8 days previously. (B) As for
(A) but analysed with a DIG-labelled oligonucleotide probe
complimentary to the 3910526-10723 nt of DENV 2 (39-probe).
(TIF)
Table S1 Sub-genomic RNA detected in sera from
dengue patients.
(DOC)
Table S2 Sequences of oligonucleotide primers em-
ployed in this study.
(DOC)
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